Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19228042rdf:typepubmed:Citationlld:pubmed
pubmed-article:19228042lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:19228042lifeskim:mentionsumls-concept:C0439810lld:lifeskim
pubmed-article:19228042lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:19228042lifeskim:mentionsumls-concept:C2000383lld:lifeskim
pubmed-article:19228042pubmed:issue6lld:pubmed
pubmed-article:19228042pubmed:dateCreated2009-3-13lld:pubmed
pubmed-article:19228042pubmed:abstractTextThe first total synthesis of ipomoeassin F was carried out using a convergent approach that relied upon the use of Schmidt glycosidation technology for the coupling of two suitably protected monosaccharide fragments. After two steps, ring-closing metathesis was used to form the macrocyclic ring, and seven more steps then furnished ipomoeassin F. In vitro inhibitory activity against a four-panel cell line showed low nanomolar inhibitory activity.lld:pubmed
pubmed-article:19228042pubmed:languageenglld:pubmed
pubmed-article:19228042pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19228042pubmed:citationSubsetIMlld:pubmed
pubmed-article:19228042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19228042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19228042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19228042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19228042pubmed:statusMEDLINElld:pubmed
pubmed-article:19228042pubmed:monthMarlld:pubmed
pubmed-article:19228042pubmed:issn1523-7052lld:pubmed
pubmed-article:19228042pubmed:authorpubmed-author:PostemaMaarte...lld:pubmed
pubmed-article:19228042pubmed:authorpubmed-author:KuznetsovGali...lld:pubmed
pubmed-article:19228042pubmed:authorpubmed-author:TenDykeKarenKlld:pubmed
pubmed-article:19228042pubmed:authorpubmed-author:XuQunliQlld:pubmed
pubmed-article:19228042pubmed:authorpubmed-author:CutterJamesJlld:pubmed
pubmed-article:19228042pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19228042pubmed:day19lld:pubmed
pubmed-article:19228042pubmed:volume11lld:pubmed
pubmed-article:19228042pubmed:ownerNLMlld:pubmed
pubmed-article:19228042pubmed:authorsCompleteYlld:pubmed
pubmed-article:19228042pubmed:pagination1417-20lld:pubmed
pubmed-article:19228042pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:meshHeadingpubmed-meshheading:19228042...lld:pubmed
pubmed-article:19228042pubmed:year2009lld:pubmed
pubmed-article:19228042pubmed:articleTitleTotal synthesis of ipomoeassin F.lld:pubmed
pubmed-article:19228042pubmed:affiliationDepartment of Discovery Chemistry, Eisai Research Institute, 4 Corporate Drive, Andover, Massachusetts 01810, USA. maarten_postema@eri.eisai.comlld:pubmed
pubmed-article:19228042pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19228042lld:pubmed